Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study
Susana Medina, Alba Gómez-Zubiaur, Nuria Valdeolivas-Casillas, Isabel Polo-Rodríguez, Lucia Ruíz, Carmen Izquierdo, Cristina Guirado, Alicia Cabrera, Lidia Trasobares
(Eur J Rheumatol 2018; 5: 224-229) DOI: 10.5152/eurjrheum.2018.18013